FDG-PET/CT links stress to increased cardiovascular event risk | Smoking kills 6M around the world each year, report finds | Study ties TNF inhibitors to lower heart attack risk in RA
January 16, 2017
ASNC SmartBrief
News for nuclear cardiology and cardiovascular imaging professionals
Top Stories
FDG-PET/CT links stress to increased cardiovascular event risk
Researchers at Massachusetts General Hospital who used FDG-PET/CT found that people with elevated activity in the amygdala, which is associated with stress, had higher odds of having a heart attack, stroke or other cardiovascular event within the next several years, compared with those with lower amygdala activity. The findings in The Lancet, based on imaging from 293 participants, suggest chronic stress could eventually be considered an important cardiovascular disease risk factor, said researcher Dr. Ahmed Tawakol.
NBC News (1/12),  HealthDay News (1/12) 
LinkedIn Twitter Facebook Google+ Email
Smoking kills 6M around the world each year, report finds
Smoking kills 6M around the world each year, report finds.
(Matt Cardy/Getty Images)
A report from the National Cancer Institute and the World Health Organization found that tobacco smoking results in about 6 million lives lost around the world each year, while more than $1 trillion is spent annually on smoking-related health care expenses and lost productivity. Health consequences include heart disease, diabetes, cancer and chronic obstructive pulmonary disease.
HealthDay News (1/10) 
LinkedIn Twitter Facebook Google+ Email
Become a future leader of Healthcare Technology
With the online MSHI from The University of Scranton, you will make data-driven healthcare decisions that keep patient-centered care at the forefront of the constantly evolving medical field. The program focuses on developing an integrative approach to patient care and will equip you with interdisciplinary tools in the healthcare informatics field. Download the brochure
Medical Focus
Study ties TNF inhibitors to lower heart attack risk in RA
An observational study in the Annals of the Rheumatic Diseases found use of tumor necrosis factor inhibitors for rheumatoid arthritis was associated with a 39% reduction in the risk of myocardial infarction, compared with use of conventional disease-modifying anti-rheumatic drugs. The findings were based on data for 14,258 patients with rheumatoid arthritis in England.
MedPage Today (free registration) (1/12) 
LinkedIn Twitter Facebook Google+ Email
Study supports government plan to reduce salt intake, CVD impact
A government-backed program to reduce salt consumption could be cost-effective and reduce intake by 10% over 10 years, saving almost 6 million life-years linked to heart disease each year, according to a study in The BMJ. The researchers said a government-supported salt reduction plan would be cost-effective in nearly every country worldwide.
HealthDay News (1/11) 
LinkedIn Twitter Facebook Google+ Email
Other News
Regulatory & Policy
US makes progress on some "Healthy People 2020" goals
US officials say eight of 26 objectives set through the "Healthy People 2020" initiative have been met or exceeded, while eight others are improving, seven show little or no change, and three are getting worse. In the area of nutrition and physical activity, the percentage of adults who met guidelines for aerobic and muscle-strengthening physical activity exceeded the 2020 goal, but there was little or no change in obesity rates for adults or children.
Medscape (free registration) (1/12) 
LinkedIn Twitter Facebook Google+ Email
House votes to start unraveling of the ACA
The House voted Friday to take initial steps to unravel the Affordable Care Act after the Senate cleared the measure earlier last week. Members of the conservative House Freedom Caucus and moderate Tuesday Group had raised concerns about their fellow Republicans' push to roll back the Affordable Care Act without establishing the specifics of a replacement plan, and Republican governors of states that expanded Medicaid eligibility also sought to focus on developing a replacement plan before rolling back the law.
The Washington Post (tiered subscription model) (1/13),  The Washington Post (tiered subscription model) (1/12),  Politico (1/13) 
LinkedIn Twitter Facebook Google+ Email
Registration now open for fellows-in-training nuclear cardiology program
The 2017 Nuclear Cardiology and Cardiac CT for Fellows-in-Training Program will cover clinical and multimodality considerations for nuclear cardiology practitioners. The program will be held immediately prior to the start of the ACC.17: Annual Scientific Session & Expo on March 16 in Washington, D.C. All cardiology, nuclear medicine and radiology fellows who are planning on attending ACC.17 are encouraged to attend; however, registration is open to all fellows-in-training. This complimentary event is co-sponsored by the American Society of Nuclear Cardiology (ASNC) and the Society of Cardiovascular Computed Tomography (SCCT). Register now for free.
LinkedIn Twitter Facebook Google+ Email
What is the best diagnostic approach for women with ischemic heart disease?
In our newly released video, a panel of experts discusses the issues in the diagnosis of ischemic heart disease in women. They explore the mechanisms of ischemia in symptomatic women and the shifting paradigm in defining coronary artery disease. Specific risk factors in women and diagnostic strategies are also discussed, as well as the challenges of diagnosing ischemic heart disease in women with heart failure. Activity is free to all participants. Offers 0.5 AMA PRA Category 1 Credits™ to physicians. View on MedPage Today.
LinkedIn Twitter Facebook Google+ Email
Learn more about ASNC:
ASNC Home | Join ASNC | Online Education
Live Meetings | Journal of Nuclear Cardiology
Do not plan for ventures before finishing what's at hand.
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Meryl Harold
P: 202.407.7828
Editor  -  Tara Rosenzweig
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information